<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0033">
 <label>33</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Singh</surname>
    <given-names>U</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chashoo</surname>
    <given-names>G</given-names>
   </name>, 
   <name name-style="western">
    <surname>Khan</surname>
    <given-names>SU</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Design of novel 3-pyrimidinylazaindole CDK2/9 inhibitors with potent in vitro and in vivo antitumor efficacy in a triple-negative breast cancer model</article-title>. 
  <source>J Med Chem</source>
  <year>2017</year>;
  <volume>60</volume>:
  <fpage>9470</fpage>–
  <lpage>89</lpage>.
  <pub-id pub-id-type="pmid">29144137</pub-id>
 </mixed-citation>
</ref>
